• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Electrocore Inc (NQ: ECOR )

    12.43 -0.91 (-6.82%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Electrocore Inc

    < Previous 1 2 3 4 Next >
    Ecora Resources PLC Announces Half year results
    Via ACCESSWIRE
    ECOR Stock Earnings: electroCore Beats EPS, Beats Revenue for Q2 2024
    ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    ECOR Stock Earnings: electroCore Beats EPS, Beats Revenue for Q1 2024
    ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    A Preview Of electroCore's Earnings
    Via Benzinga
    iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023
    Via ACCESSWIRE
    electroCore Earnings Perspective: Return On Capital Employed
    Via Benzinga
    electroCore: Q1 Earnings Insights
    Via Benzinga
    Electrocore Inc. (NASDAQ: ECOR) Near the Top of Equities by Percentage Gain on 3/24
    Via Investor Brand Network
    Earnings Scheduled For March 13, 2024
    Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    electroCore Earnings Perspective: Return On Capital Employed
    Via Benzinga
    A Preview Of electroCore's Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
    The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms
    electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
    Pre-clinical trial demonstrates the ability of nVNS to decrease the amount of brain injury, decrease anxiety and improve motor function post injury 
    From electroCore, Inc.
    Via GlobeNewswire
    electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
    From electroCore, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
    Poster Highlights the Ability of Non-Invasive Vagus Nerve Stimulation (nVNS) to Accelerate Learning of a Second Language 
    From electroCore, Inc.
    Via GlobeNewswire
    electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
    From electroCore, Inc.
    Via GlobeNewswire
    electroCore to Participate at 35th Annual Roth Conference
    From electroCore, Inc.
    Via GlobeNewswire
    7 Stocks to Sell as Borrowing Costs Rise
    With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell. 
    Via InvestorPlace
    Earnings Scheduled For March 8, 2023
    Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
    Via Benzinga
    electroCore Regains Compliance with Nasdaq Listing Requirements
    From electroCore, Inc.
    Via GlobeNewswire
    electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
    From electroCore, Inc.
    Via GlobeNewswire
    10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More
    Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
    Via Benzinga
    electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
    From electroCore, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.